bpc-157 mechanism of action The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Stable Gastric Pentadecapeptide BPC 157

The combination of GLP-1 receptor agonists with amylin analogues or future ghrelin receptor-targeting therapies may provide greater reductions in body weight and adiposity than monotherapy

C.-H. Chang, W.-C. Tsai, Y.-H. Hsu, and J.-H. Pang, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, MDPI AG, Nov. 2014. doi: 10.3390/molecules191119066

## Dose Calculation Reference (10mg/ml) | Desired Dose | Volume to Draw | Insulin Syringe Units | |-------------|----------------|----------------------| | 1mg | 0.10ml | 10 units | | 2mg | 0.20ml | 20 units | | 4mg | 0.40ml | 40 units | | 8mg | 0.80ml | 80 units | | 12mg | 1.20ml | Split: 0.60ml x 2 | **Formula:** Dose (mg) / Concentration (mg/ml) = Volume (ml) For doses requiring more than 1ml, split into two injection sites administered the same day

Then, we teach patients how to give themselves additional shots and are sent home with preloaded syringes to self-inject every other day for two weeks